Humacyte, Inc. (Nasdaq: HUMA) is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. The Company develops and manufactures acellular tissues to treat a wide range of diseases, injuries and chronic conditions. Humacyte’s initial opportunity, a portfolio of human acellular vessels (HAVs), is currently in late-stage clinical trials targeting multiple vascular applications, including vascular trauma repair, arteriovenous access for hemodialysis, and peripheral arterial disease. Preclinical development is also underway in coronary artery bypass grafts, pediatric heart surgery, treatment of type 1 diabetes, and multiple novel cell and tissue applications. Humacyte’s 6mm HAVs for AV access for performing hemodialysis was the first product candidate to receive the FDA’s Regenerative Medicine Advanced Therapy (RMAT) expedited review designation, and the HAV technology received priority designation for the treatment of vascular trauma by the U.S. Secretary of Defense. For more information, visit www.Humacyte.com.

Based in Cary, NC, Atticus, LLC is an American-owned, bootstrapped and independently operated company. Atticus offers a broad and expanding portfolio of relevant, branded-generic pesticides for Agriculture and EcoCore markets. Driven by grassroots experience and an unwavering commitment to operational excellence, Atticus is an ally uniquely positioned to focus on long-term decisions that benefit retail distribution, the beautification of surroundings and the protection of essential infrastructure. Bringing products to market that complement agronomic and business needs is how Atticus helps retail distributors and end-users get the most out of their input requirements.

At Asymchem we are proud of the strides that we have made since our founding in 1999, providing R&D and one-stop production services to the world’s top pharmaceutical companies. Driving our success is our commitment to continual optimization and investing in the future. By improving the capabilities our partners need now, and maintaining the agility needed to support innovation, we’ve built a knowledge and experience base that we’re ready to share. Our solutions range from early clinical stage to commercial stage, including R&D and cGMP production of advanced intermediates, APIs, formulations, as well as clinical research services. Through strategic partnerships and calculated business growth, we have built an integrated service ecosystem. Our 8 R&D and manufacturing sites are located in P.R. China and are regularly inspected by regulatory bodies such as the USFDA. Our expertise lies in developing and applying innovative technologies such as green chemistry for scaleup of technically complex API's, with the added advantage of in-house raw materials'​ manufacturing to control availability and lead-times. From initial development of a synthetic chemical process through to manufacturing, Asymchem’s proven team of experienced process and engineering teams has the knowledge to help our clients get things done. Asymchem's toolbox of capabilities include continuous flow reactions technologies, biocatalysis, asymmetric synthesis, HPAPI, cryogenic, catalytic hydrogenation, and others.

SBM Life Science offers innovative and responsible solutions and services to its customers and consumers for their plants, gardens, and living environments. Its range of products includes plant protection, soil and lawn seeds, plant food, and pest and mosquitoes control products to meet consumers’ needs: to Nourish, Beautify, Maintain, and Defend. SBM Life Science has several flagship brands in Europe: Protect Home®, Protect Garden® and Solabiol®, a pioneer in natural products in France since 2001. High-performing local brands complete the company’s offer in each European country, such as NutriOne®, Phostrogen® and Stroller®. In the United States, SBM Life Science Corp. is a key player in innovation in the lawn and garden market and stands with leading brands such as BioAdvanced® and Natria®, one of the leading brands in organic products. Recognized by its employees internationally, SBM Life Science was awarded Great Place To Work® certification in Europe in 2022, a recognition that echoes that obtained in the United States in 2021. In France, as part of the JardinPlus® 2022 Awards, SBM Life Science was elected Supplier of the Year by purchasing decision-makers from the retail sector. SBM Life Science, with 450 employees in 22 locations worldwide, is the Home & Garden subsidiary of the SBM Company. The group is positioned in four areas of activity: - agricultural crop protection, through the commercial entity CMPA - industrial production, with six plants (five in France and one in the United States) https://www.linkedin.com/company/sbm-formulation/ - aromatherapy, under the LCA brands https://www.linkedin.com/company/lca-aroma/ - Garden & Home, the group's main activity, with its subsidiaries SBM Life Science in Europe and the United States and the subsidiaries SPG and Or Brun in France. For more information: https://sbm-company.com/

As a medium sized, family-owned company in its second generation we are known internationally as a "Specialist for Macromolecular Chemistry"​. Starting with the development of polymer dispersions for adhesives, our core business, today, is the development, production, and marketing of polymers in the form of emulsions, solutions, or as mass polymers.

ENSYSTEX was founded in 1994 by pest control operators intent on changing the landscape of the professional pest control industry. To our knowledge, our effort represents the first time that pest control operators have ever started a chemical company intent on developing and marketing products for the industry. In the face of a structural pest control industry dominated by a few large chemical companies, we fully understand why it has been difficult for many PCOs to take our small effort seriously, however the registration of our bait product, Labyrinth and our subsequent registration of a multitude of additional pest control products, should serve as a wake-up call to those that doubted the extent of our commitment or our willingness to devote the necessary resources to bringing these products to market. More than anything else, the development of EXTERRA and the Thor line of products is proof of what devotion to an idea by a small group of individuals working together can accomplish. Our ever-increasing list of pest control professionals is proof that this idea has truly met the needs of our structural pest control industry.

NIOX is a hospitality company based out of 134 Avenue Franklin Roosevelt, Bruxelles, Belgium.

NightHawk Biosciences is a fully integrated biopharmaceutical company focused on the development of new drugs from discovery through commercialization. The Company leverages its integrated ecosystem of subsidiaries to accelerate the creation and manufacture of novel therapies that arm the immune system, breaking through barriers that prolong traditional drug development. This empowers us to bring our ideas to life with efficient control, superior quality, and uncharacteristic agility.

Next generation CRISPR technology for programmed cell death. Focused on developing therapies for infectious disease and the microbiome. Locus Biosciences’ novel approach to precision antimicrobials works by taking advantage of a part of an immune system present in many bacteria called the CRISPR-Cas system. The CRISPR-Cas system protects bacteria from invaders such as viruses by creating small strands of RNA called CRISPR RNAs, which match DNA sequences specific to a given invader. When the CRISPR RNAs find a match, they activate Cas proteins that cut the DNA. Locus Biosciences has developed a platform to design and deliver custom CRISPR-Cas systems directly to specific bacteria. Guided by the custom Locus Bio CRISPRs, the Type-I Cas proteins work to destroy bacterial DNA and cause the bacterial targets to “self-destruct”. Locus’ platform enables the development of antimicrobials which avoid currently known resistance mechanisms while leaving non-target bacteria unharmed. Built on prokaryotic technology for prokaryotic targets, Locus is advancing its platform to create therapeutics for critical-need therapeutic areas ranging from resistant bacterial infections to the microbiome.

The Department of Health and Human Services manages the delivery of health- and human-related services for all North Carolinians, especially our most vulnerable citizens – children, elderly, disabled and low-income families. The Department works closely with health care professionals, community leaders and advocacy groups; local, state and federal entities; and many other stakeholders to make this happen. The Department is divided into 30 divisions and offices. NCDHHS divisions and offices fall under four broad service areas - health, human services, administrative, and support functions. NCDHHS also oversees 14 facilities: developmental centers, neuro-medical treatment centers, psychiatric hospitals, alcohol and drug abuse treatment centers, and two residential programs for children. Mission: In collaboration with our partners, DHHS provides essential services to improve the health, safety and well-being of all North Carolinians. Vision: Advancing innovative solutions that foster independence, improve health and promote well-being for all North Carolinians. Values: People-Focused Focus on the people we serve, deliver value and make a positive impact on their lives and communities. Teamwork We are all one department, one team, working toward one goal: to improve the health, safety and well-being of all North Carolinians. Proactive Communication Maintain an open and trusting environment for collaboration and continuous improvement with our team, stakeholders and the people we serve. Transparency Share expertise, information and honest feedback within the Department and with stakeholders and the community. Ask for help when needed. Stewardship Be good stewards of resources and time to create a positive impact for those we serve. Joy Have joy and balance at work so we all bring our A-game when serving the people of North Carolina.

At Vive, we create Precision Chemistry™ that simplifies crop production and delivers real results to growers. Powered by Vive's patented Allosperse® Delivery Technology, we optimize conventional and biological crop inputs for improved product performance from the jug to the field. Vive’s Precision Chemistry solutions can be tank mixed, worry-free, with liquid fertilizers, micronutrients, hard water, and other crop inputs for a more flexible, efficient, and convenient planting or foliar spray operation. You will get proven performance AND save on time, labor, and fuel by getting more done at once!

BioMedomics is the clinical diagnostics company that delivers accurate, quick, simple and affordable solutions for use anywhere, anytime. Our products provide immediate answers wherever you are. No waiting. They provide results equivalent to a large laboratory, but at the point of care. And they use cutting edge technology to achieve reliable results.